Literature DB >> 11478388

Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases.

P A Watkins1, J A Hamilton, A Leaf, A A Spector, S A Moore, R E Anderson, H W Moser, M J Noetzel, R Katz.   

Abstract

The brain is rich in diverse fatty acids saturated, monounsaturated and polyunsaturated fatty acids with chain lengths ranging from less than 16 to more than 24 carbons that make up the complex lipids present in this organ. While some fatty acids are derived from endogenous synthesis, others must come from exogenous sources. The mechanism(s) by which fatty acids enter cells has been the subject of much debate. While some investigators argue for a protein-mediated process, others suggest that simple diffusion is sufficient. In the brain, uptake is further complicated by the presence of the blood-brain barrier. Brain fatty acid homeostasis is disturbed in many human disorders, as typified by the peroxisomal biogenesis diseases. A workshop designed to bring together researchers from varied backgrounds to discuss these issues in an open forum was held in March, 2000. In addition to assessing the current state of knowledge, areas requiring additional investigation were identified and recommendations for future research were made. A brief overview of the invited talks is presented here.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478388     DOI: 10.1385/JMN:16:2-3:87

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  23 in total

Review 1.  Fatty acid transporters in animal cells.

Authors:  T Y Hui; D A Bernlohr
Journal:  Front Biosci       Date:  1997-05-15

2.  Fish consumption and major depression.

Authors:  J R Hibbeln
Journal:  Lancet       Date:  1998-04-18       Impact factor: 79.321

3.  Fatty acid transport and utilization for the developing brain.

Authors:  J Edmond; T A Higa; R A Korsak; E A Bergner; W N Lee
Journal:  J Neurochem       Date:  1998-03       Impact factor: 5.372

Review 4.  Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: therapeutic implications.

Authors:  M Martinez
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.

Authors:  A L Stoll; W E Severus; M P Freeman; S Rueter; H A Zboyan; E Diamond; K K Cress; L B Marangell
Journal:  Arch Gen Psychiatry       Date:  1999-05

6.  The beta-oxidation of arachidonic acid and the synthesis of docosahexaenoic acid are selectively and consistently altered in skin fibroblasts from three Zellweger patients versus X-adrenoleukodystrophy, Alzheimer and control subjects.

Authors:  A Petroni; B Bertagnolio; P La Spada; M Blasevich; N Papini; S Govoni; M Rimoldi; C Galli
Journal:  Neurosci Lett       Date:  1998-07-10       Impact factor: 3.046

7.  Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study.

Authors:  M Martinez; I Mougan; M Roig; A Ballabriga
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

8.  Quantitative brain autoradiography of [9,10-3H]palmitic acid incorporation into brain lipids.

Authors:  J G Noronha; J M Bell; S I Rapoport
Journal:  J Neurosci Res       Date:  1990-06       Impact factor: 4.164

9.  Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes.

Authors:  W Stremmel; G Strohmeyer; F Borchard; S Kochwa; P D Berk
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

10.  MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders.

Authors:  M Martinez; E Vazquez
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

View more
  7 in total

1.  The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk.

Authors:  E E M Knowles; K Huynh; P J Meikle; H H H Göring; R L Olvera; S R Mathias; R Duggirala; L Almasy; J Blangero; J E Curran; D C Glahn
Journal:  Eur Psychiatry       Date:  2017-02-21       Impact factor: 5.361

2.  Determining the Bioenergetic Capacity for Fatty Acid Oxidation in the Mammalian Nervous System.

Authors:  Cory J White; Jieun Lee; Joseph Choi; Tiffany Chu; Susanna Scafidi; Michael J Wolfgang
Journal:  Mol Cell Biol       Date:  2020-04-28       Impact factor: 4.272

3.  Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein.

Authors:  Christopher E Ellis; Eric J Murphy; Drake C Mitchell; Mikhail Y Golovko; Fernando Scaglia; Gwendolyn C Barceló-Coblijn; Robert L Nussbaum
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

4.  Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders.

Authors:  James A Hamilton; Cecilia J Hillard; Arthur A Spector; Paul A Watkins
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

Review 5.  Nutrient Sensing: Another Chemosensitivity of the Olfactory System.

Authors:  A-Karyn Julliard; Dolly Al Koborssy; Debra A Fadool; Brigitte Palouzier-Paulignan
Journal:  Front Physiol       Date:  2017-07-12       Impact factor: 4.566

Review 6.  The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants.

Authors:  Maria Fernanda Fernandes; David M Mutch; Francesco Leri
Journal:  Nutrients       Date:  2017-03-17       Impact factor: 5.717

Review 7.  Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?

Authors:  Cristiana Tanase; Ana Maria Enciu; Elena Codrici; Ionela Daniela Popescu; Maria Dudau; Ana Maria Dobri; Sevinci Pop; Simona Mihai; Ancuța-Augustina Gheorghișan-Gălățeanu; Mihail Eugen Hinescu
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.